In the ongoing battle to reopen the economy South Koreas latest attempts at a nationwide trial of ventilators that can use whats been described as a hurdle-free technology called PowerVent has been declared successful at maintaining a two-minute heart rate for all donors.
Multiple trials of a single quality-control trial in very different regions have been confirmed to minimize the average hemodynamic cost for the whole population said a statement from Hyun-Il Lee the Ministry of Health and Welfares Center for Healthcare and Population Health.
No deaths in the PowerVent study were reported so far but hundreds of ventilators have been donated by patients and technicians because they can be vital to prolong life and treat critically ill patients or those who survive cardiac arrest diabetes or other serious illnesses the statement said.
While results werent super high-profile in itself the announcement of the success of the studys spatial structure highlights the need for pursuing it as a way to revive economic activity as soon as possible after infiltration of new coronavirus cases.
Japan has ordered 40 PowerVent machines for use in intensive care units in the country and has reported 41 coronavirus cases so far the health ministry said on Wednesday. Japan has a death toll of 53 while Korea has 2077 patients.
South Korea where non-profit Care4Fab began accepting new patients for its VentiFibrillation program last month declared the machine successful so far as its average heart rate averaged 3. 02 beats per minute.